Article pdf download
Publication Certificate


Collagen disorder, Autoantibodies. Autoimmune diseases. AyurvedicTreatment

How to Cite

Bhokardankar, P. S., Mane, S. G., & Khairnar, B. P. (2019). A CASE REPORT OF CONNECTIVE TISSUE DISORDER- AN AYURVEDIC APPROACH. Ayurline: IJ-RIM, 3(04). Retrieved from http://ayurline.in/index.php/ayurline/article/view/264


Connective tissue disease (CTDs), though rare in kids, is an important cause of morbidity. By general physician mostly misunderstood by rheumatoid arthritis. most of them involve multiple organ systems and are associated with presence of auto antibodies. Systemic lupus erythematosus (SLE) is the most common CTD, the others being Juvenile dermatomyositis, systemic sclerosis, mixed connective disease and Sjogren syndrome. The clinical presentation of CTD in childhood can range from an acute severe illness mimicking a serious infection, to an insidious onset of disease with gradual accumulation of symptoms and signs over weeks to months. The presence of multi-system involvement, evidence of inflammation and lack of any obvious cause should alert a clinician to the possibility of CTD. Diagnosis is usually clinical and features like malar rash, Raynaud’s phenomenon, photosensitivity, oral ulcers suggest a possibility of CTD. Presence of autoantibodies like anti-nuclear antibodies etc. provide supportive evidence to a diagnosis of CTD. Most CTDs are treated with immunosuppressive drugs with good success. The rationale for using Ayurvedic medicines is to restore normal life style and reverse the condition with lesser side effects. Patient of 11 years old was treated with an Ayurvedic formulations to replace the modern drugs. The patient got significant result with the help of Ayurvedic medicines.

Article pdf download
Publication Certificate


1.Denchenko N et al, Epidemiology of SLE,A comparison of worldwide disease burden.Lupus.200615(5);308-18
2.Malviya et al,Prevalence of systemic lupus erythematous in India,SAGE Journals 1993,2(2):115-18
3.Anderson MS International Society for clinical Densiotometry,Annual meeting,Journal of Clinical Endocrinology and Metabolism,2008;93(10)
4.Kajariwal et al,PUO,A perspective study of 100 casesJPGM.2001;104-07
5.Abdelbaky MS et al, Hassan prevalence of connective tissue diseases in Egyptian patients presenting PUO 2011,4;33-41
6.Kosaraju K shenoy,et al, A cross sectional hospital-based study of autoantibody profile and clinical manifestations of Systemic lupous erythematous in south Indian patients Indian journal of Medical Microbiology.2010:28(3);245-47
7.Pradhan et al Clinical and autoimmune profile of scleroderma patients from Western India, Journal of Rheumatology ;2014;2014;983781
8. Shri Baidyanath Ayurved Bhavan Ltd, Nagpur, Ayurved Sar Sangraha, 20th Edition – 2000, P- 722.
9. Acharya Yadava ji Trikam ji Siddha Yog Sangraha, Shri Baidyanath Ayurved Bhavan, Nagpur, 8th Edition, July 1984, P- 4
10. Shri Baidyanath Ayurved Bhavan Ltd, Nagpur, Ayurved Sar Sangraha, 20th Edition – 2000, P- 385.
11. Dr. Siddhinadan Mishra, Ayurved Rasashastra, 15th edition, Chaubhambha Orientalia, Varanasi, 2006, P- 564 – 566.
12. Shastri Kashinath, Rasatarangini, Motilal Publication, Delhi, 11th Edition, 1979, P- 627.
13. Shri Sadanand Sharma, Rasatarangini, Motilal Publication, 1986, P- 284.
14. Kwon H-M et al, Blockade of cytokine induced endothelial cell adhesion molecule expression by licorice isoliquiteritigenin through Nf-kB signal disruption. Experimental Biology and Medicine,2007,232(2)235-245.

I  declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein. All agreed to the terms and conditions, Privacy Policy, which is declared on Journal Website http://www.ayurline.in and online filled (uploaded) form


Download data is not yet available.